The partnership integrates advanced AI-driven analytics and clinical trial solutions, empowering biopharma companies to accelerate drug development and deliver targeted therapies faster.
Precision for Medicine, a...
Xaira is an integrated biotechnology company built to deliver on the promise of artificial intelligence to help transform drug discovery and development
Xaira Therapeutics announced...
The Next platform will analyze clinical data from mBC patients treated in certain centers and notify clinicians when ESR1 testing is missing at disease progression.
Tempus AI,...
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announced a new collaboration with the...
The collaboration brings together Caris' extensive genomic data and molecular expertise with Ontada's robust clinical data and research capabilities to drive next-gen therapeutic development...
Myant Corp., a leader in chronic disease prevention through precision medicine, announced the acquisition of mmHg Inc., a digital health company specializing in remote...
Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, announced that it has raised $34 million in Series...